215 related articles for article (PubMed ID: 31054897)
21. GATA3 expression in sarcomatoid urothelial carcinoma of the bladder.
Fatima N; Osunkoya AO
Hum Pathol; 2014 Aug; 45(8):1625-9. PubMed ID: 24824028
[TBL] [Abstract][Full Text] [Related]
22. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems.
Oliva E; Amin MB; Jimenez R; Young RH
Am J Surg Pathol; 2002 Feb; 26(2):190-7. PubMed ID: 11812940
[TBL] [Abstract][Full Text] [Related]
23. Molecular profile of urothelial carcinoma of the upper urinary tract: are pelvicalyceal and ureteral tumors different?
Krabbe LM; Bagrodia A; Westerman ME; Gayed BA; Haddad AQ; Sagalowsky AI; Shariat SF; Kapur P; Lotan Y; Margulis V
World J Urol; 2016 Jan; 34(1):105-12. PubMed ID: 25991599
[TBL] [Abstract][Full Text] [Related]
24. Invasive plasmacytoid urothelial carcinoma: A comparative study of E-cadherin and P120 catenin.
Sangoi AR; Chan E; Stohr BA; Kunju LP
Hum Pathol; 2020 Aug; 102():54-59. PubMed ID: 32673685
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls.
Paner GP; McKenney JK; Barkan GA; Yao JL; Frankel WL; Sebo TJ; Shen SS; Jimenez RE
Am J Surg Pathol; 2011 Jun; 35(6):787-98. PubMed ID: 21572312
[TBL] [Abstract][Full Text] [Related]
26. A four-antibody immunohistochemical panel can distinguish clinico-pathological clusters of urothelial carcinoma and reveals high concordance between primary tumor and lymph node metastases.
Bontoux C; Rialland T; Cussenot O; Compérat E
Virchows Arch; 2021 Apr; 478(4):637-645. PubMed ID: 33128085
[TBL] [Abstract][Full Text] [Related]
27. Plasmacytoid urothelial carcinoma of the bladder.
Qin M; Wang G; Sun Y; He Q
Indian J Pathol Microbiol; 2014; 57(2):320-2. PubMed ID: 24943778
[TBL] [Abstract][Full Text] [Related]
28. Multiple but different urothelial tumours in one side of a urinary tract.
Shokeir AA; el-Baz M; el-Diasty TA; el-Mekresh M; Abdel Gawad M
Scand J Urol Nephrol; 1997 Apr; 31(2):199-201. PubMed ID: 9165587
[TBL] [Abstract][Full Text] [Related]
29. H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three cases.
Castillo-Martin M; Collazo Lorduy A; Gladoun N; Hyun G; Cordon-Cardo C
J Pediatr Urol; 2016 Apr; 12(2):91.e1-7. PubMed ID: 26522772
[TBL] [Abstract][Full Text] [Related]
30. GATA3 expression in paragangliomas: a pitfall potentially leading to misdiagnosis of urothelial carcinoma.
So JS; Epstein JI
Mod Pathol; 2013 Oct; 26(10):1365-70. PubMed ID: 23599157
[TBL] [Abstract][Full Text] [Related]
31. [Determination of urinary CA19-9 levels in urothelial cancer--assessment of its role in diagnosis].
Noto K; Fujime M; Isobe H; Wakumato Y; Kawachi Y
Nihon Hinyokika Gakkai Zasshi; 1997 Mar; 88(3):406-13. PubMed ID: 9125864
[TBL] [Abstract][Full Text] [Related]
32. Tissue polypeptide antigen and carcinoembryonic antigen lack diagnostic accuracy in urothelial carcinoma.
Stefanović V; Mitić-Zlatković M; Ignjatović I; Vlajković M; Sćepović Z
Int Urol Nephrol; 1999; 31(4):443-9. PubMed ID: 10668938
[TBL] [Abstract][Full Text] [Related]
33. Plasmacytoid urothelial carcinoma of the urinary bladder-A clinicopathological and molecular analysis of 52 cases.
Zheng L; Chen H; Zhao J; Roy-Chowdhuri S; Kamat AM; Alhalabi O; Gao J; Siefker-Radtke A; Hansel DE; Czerniak B; Guo CC
Hum Pathol; 2024 Jun; 148():1-6. PubMed ID: 38679207
[TBL] [Abstract][Full Text] [Related]
34. Poorly differentiated transitional cell carcinoma versus leiomyosarcoma of the ureter: different defects in tumour suppressor genes.
Tzen CY; Wu CJ; Huang ZD; Wu TY
Histopathology; 2007 Aug; 51(2):271-3. PubMed ID: 17593211
[No Abstract] [Full Text] [Related]
35. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].
Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR
Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751
[TBL] [Abstract][Full Text] [Related]
36. Small cell carcinoma of urinary bladder is differentiated from urothelial carcinoma by chromogranin expression, absence of CD44 variant 6 expression, a unique pattern of cytokeratin expression, and more intense gamma-enolase expression.
Iczkowski KA; Shanks JH; Allsbrook WC; Lopez-Beltran A; Pantazis CG; Collins TR; Wetherington RW; Bostwick DG
Histopathology; 1999 Aug; 35(2):150-6. PubMed ID: 10460660
[TBL] [Abstract][Full Text] [Related]
37. Expression of CD44V2 in transitional cell carcinoma of the urinary bladder and in urine.
Müller M; Heicappell R; Habermann F; Kaufmann M; Steiner U; Miller K
Urol Res; 1997; 25(3):187-92. PubMed ID: 9228671
[TBL] [Abstract][Full Text] [Related]
38. A Simple Immunohistochemical Panel Could Predict and Correlate to Clinicopathologic and Molecular Subgroups of Urinary Bladder Urothelial Carcinoma.
Makboul R; Hassan HM; Refaiy A; Abdelkawi IF; Shahat AA; Hameed DA; Morsy A; Salah T; Ahmed Mohammed RA
Clin Genitourin Cancer; 2019 Jun; 17(3):e712-e719. PubMed ID: 31085058
[TBL] [Abstract][Full Text] [Related]
39. Unusual clinical presentation of upper urothelial carcinoma in Taiwan.
Chou YH; Huang CH
Cancer; 1999 Mar; 85(6):1342-4. PubMed ID: 10189140
[TBL] [Abstract][Full Text] [Related]
40. Plasmacytoid urothelial carcinoma of the bladder.
Lopez-Beltran A; Requena MJ; Montironi R; Blanca A; Cheng L
Hum Pathol; 2009 Jul; 40(7):1023-8. PubMed ID: 19297008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
